Compare BDTX & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | KG |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 118.0M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | KG |
|---|---|---|
| Price | $2.16 | $9.59 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.20 | N/A |
| AVG Volume (30 Days) | ★ 607.9K | 20.1K |
| Earning Date | 03-16-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.35 | ★ $1.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $8.07 |
| 52 Week High | $4.94 | $35.37 |
| Indicator | BDTX | KG |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 31.12 |
| Support Level | $1.93 | $8.07 |
| Resistance Level | $2.86 | $10.74 |
| Average True Range (ATR) | 0.14 | 0.94 |
| MACD | -0.00 | -0.53 |
| Stochastic Oscillator | 38.39 | 8.88 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Kestrel Group Ltd is specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.